Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-01-09

Clinical Trial Update: Clinical Response to Rhinovirus Challenge [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing clinical response to rhinovirus challenge in participants with asthma and allergic rhinitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Virginia | Conditions: Asthma, Allergic Rhinitis | Phase 2 | Status: COMPLETED | Results posted: 2024-01-09